Abiopharma

🔍 Goldstein Brian Steven (Director)

Company: INNOVATE Corp. (VATE)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Acquired 12,016 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 60,999.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, as amended (the "Plan"). The shares will vest and become non-forfeitable on the earlier of (i) the first anniversary of the grant date and (ii) the first regular annual meeting of the Company's stockholders that occurs following the date of grant (subject to continued service with the Company through such vesting date).